City page
Horsholm biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Biotech (2), Manufacturing (1), and CRO (1). Most visible records: Visiopharm, Gubra, and ExpreS2ion Biotechnologies.
Which standards and public evidence are already visible?
GMP (1). Latest review: 21 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Horsholm.
By category
Horsholm by category
Jump into a category page filtered to this country only.
Full list
Horsholm biotech and pharma directory
5 city records currently match the active filter.
Current review cycle
Visiopharm
HorsholmDenmarkDiagnostics
Horsholm diagnostics company operating a digital pathology and precision-image-analysis platform for tissue diagnostics and translational research.
- Lead
- Michael GrunkinCEO
- Scale
- Commercial diagnostics platform
Current review cycle
Gubra
HorsholmDenmarkCRO
Horsholm preclinical CRO and biotech platform providing obesity, metabolic-disease, peptide, and drug-discovery services and programs.
- Lead
- Henrik BlouCEO
- Scale
- Commercial preclinical CRO platform
Current review cycle
ExpreS2ion Biotechnologies
HorsholmDenmarkBiotech
Horsholm biotech company operating a protein-expression and vaccine-development platform for infectious-disease and therapeutic applications.
- Lead
- Bent U. FrandsenCEO
- Scale
- Specialized biotech platform
Current review cycle
Novonesis
HorsholmDenmarkBiotech
Horsholm biosolutions company combining industrial biotechnology, enzymes, and microbial platforms across food, agriculture, pharma, and bioprocess applications from Denmark.
- Lead
- Ester BaigetPresident and CEO
- Scale
- Enterprise biosolutions and fermentation platform
Current review cycle
ALK-Abelló
HorsholmDenmarkManufacturing
Hørsholm allergy-immunotherapy headquarters and production-control node anchored in standardized vaccine manufacturing and quality systems.
- Lead
- Peter HallingPresident and Chief Executive Officer
- Scale
- Commercial specialty manufacturing
Related briefs
Briefs that mention Horsholm
European mRNA & Immunotherapy Supply Chain 2026
Where the European mRNA, vaccine, and immunotherapy supply chain actually sits in 2026 — BioNTech, CureVac, IDT Biologika, AGC Biologics, BioSpring, Bachem, plus the Nordic vaccine layer — and how the pieces fit.
Open briefNordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 — Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.